Scientists created an online cell atlas containing information on the gene activity of more than 300,000 lung cells taken…
Articles by Joana Carvalho, PhD
Veracyte’s Envisia Genomic Classifier, the first commercially available genomic test to help diagnose idiopathic pulmonary fibrosis (IPF),…
Stem cells derived from the placental amniotic membrane — one of the membranes of the amniotic sac that surrounds a…
The U.S. Food and Drug Administration (FDA) has designated AMP945, Amplia Therapeutics’ investigational anti-fibrotic therapy for idiopathic pulmonary…
Repeat hospitalizations for respiratory problems in people with chronic idiopathic interstitial pneumonia (c-IIP) — a group of chronic lung…
The French Medicines Agency has authorized Genkyotex to launch a Phase 1 trial to evaluate the safety and…
GB0139, Galecto’s lead compound to treat various fibrotic diseases of the lungs, has shown strong anti-fibrotic activity in…
Loss of NEDD4-2 — a protein involved in the regulation of airway hydration and mucus clearance — leads to…
Mechanical ventilation is associated with higher mortality rates in hospitalized patients with idiopathic pulmonary fibrosis (IPF) and acute…
Avalyn Pharma announced that it has raised $35.5 million in Series B funding to expand its pipeline and…